Login to Your Account

$69 and Holding

Sanofi Goes Hostile: Takes Bid to Genzyme Shareholders

By Jennifer Boggs

Tuesday, October 5, 2010
Genzyme Corp. urged shareholders to take no action on Sanofi-Aventis SA's anticipated hostile takeover attempt – at the previously twice-rejected $69 per-share offering price – but whether the large biotech is able to command a higher bid remains debatable. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription